Only logged in members can reply and interact with the post.
Join SimilarWorlds for FREE »

As biotech company Moderna announced promising early results for its coronavirus vaccine, the chief financial and medical officers sold thousands of

shares. lol, If the drug is so promising, why would chief financial and medical officers sell all those shares?
Picklebobble2 · 56-60, M
Company makes sensationalist claim.
Media picks up on sensationalist claim.
Company founders and board buy stock but issue stock options.
Company watches stock/share price rise.
Larger company buys out smaller company for exhorbitant sum.
Larger company now owns so called sensational drug.
Drug sold at 100 times it's real value.
Elessar · 26-30, M
Probably they fear the competition.

[u]https://www.reuters.com/article/us-health-coronavirus-astrazeneca/us-secures-300-million-doses-of-potential-astrazeneca-covid-19-vaccine-idUSKBN22X0J9[/u]
They wouldn't, the CMO has been pushed out for objecting the the vaccine is no good. CFO has sold prior to the announcement that the CMO is leaving, the shares will fall and he'll buy back at a lower price
Picklebobble2 · 56-60, M
Lot of this going around.
Nika2002 · 22-25, F
Maybe they got big money on the sold shares. And it reduces their risk from lost cash liquidity.
SW-User
@Nika2002 Yeah, but if the vaccines actually worked, I'm sure they would make a lot more money by keeping the shares.
Nika2002 · 22-25, F
@SW-User Manufacturing startup carries a hefty price tag.
SW-User
@Nika2002 That's what the public offering of common stock is about. These were their personally owned shares.
To raise the funds required for continued research and development.
tallpowerhouseblonde · 31-35, F
@hartfire It does not work like that.Shares are individually owned.The share sale will not raise money for the company.Only the original flotation and releasing new shares does that.
@tallpowerhouseblonde Yes, I knew that, but I made the mistake of thinking that when you talked of the med and tech staff selling shares, it was because they were launching a new prospectus.
If they're selling shares they already own in the company, that's a mystery, unless they already know that there's something wrong with their research or the company's business prospects.
JoeMW · 51-55, M
He's Trump's new "vaccine czar" so he had to sell to avoid conflict of interest laws
MarineBob · 56-60, M
Probably sold really cheap to a politicians family
Zaxel · 26-30, M
how many shares sold in relation to their total holdings?

 
Post Comment